These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 35250605)

  • 1. Histone Deacetylases as Modulators of the Crosstalk Between Skeletal Muscle and Other Organs.
    Renzini A; D'Onghia M; Coletti D; Moresi V
    Front Physiol; 2022; 13():706003. PubMed ID: 35250605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism.
    Molinari S; Imbriano C; Moresi V; Renzini A; Belluti S; Lozanoska-Ochser B; Gigli G; Cedola A
    Front Mol Biosci; 2023; 10():1130183. PubMed ID: 37006625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines.
    Kirk B; Feehan J; Lombardi G; Duque G
    Curr Osteoporos Rep; 2020 Aug; 18(4):388-400. PubMed ID: 32529456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus.
    Dewanjee S; Vallamkondu J; Kalra RS; Chakraborty P; Gangopadhyay M; Sahu R; Medala V; John A; Reddy PH; De Feo V; Kandimalla R
    Cells; 2021 May; 10(6):. PubMed ID: 34071497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease.
    Wang ZY; Qin W; Yi F
    J Geriatr Cardiol; 2015 Mar; 12(2):153-64. PubMed ID: 25870619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
    Eom GH; Kook H
    Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Histone Deacetylases in Skeletal Muscle Physiology and Systemic Energy Homeostasis: Implications for Metabolic Diseases and Therapy.
    Tian H; Liu S; Ren J; Lee JKW; Wang R; Chen P
    Front Physiol; 2020; 11():949. PubMed ID: 32848876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors: Potential in cancer therapy.
    Marks PA; Xu WS
    J Cell Biochem; 2009 Jul; 107(4):600-8. PubMed ID: 19459166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose-Muscle crosstalk in age-related metabolic disorders: The emerging roles of adipo-myokines.
    Fang P; She Y; Yu M; Min W; Shang W; Zhang Z
    Ageing Res Rev; 2023 Feb; 84():101829. PubMed ID: 36563906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases.
    Kulthinee S; Yano N; Zhuang S; Wang L; Zhao TC
    Pathophysiology; 2022 Aug; 29(3):471-485. PubMed ID: 35997393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibition improves metabolism and mitochondrial dynamics: A potential novel therapeutic strategy for sarcopenia coexisting with diabetes mellitus.
    Lee TW; Liu HW; Lin YF; Lee TI; Kao YH; Chen YJ
    Med Hypotheses; 2021 Oct; 158():110724. PubMed ID: 34753007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute inhibition of protein deacetylases does not impact skeletal muscle insulin action.
    Martins VF; Begur M; Lakkaraju S; Svensson K; Park J; Hetrick B; McCurdy CE; Schenk S
    Am J Physiol Cell Physiol; 2019 Nov; 317(5):C964-C968. PubMed ID: 31461343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).
    Lawson M; Uciechowska U; Schemies J; Rumpf T; Jung M; Sippl W
    Biochim Biophys Acta; 2010; 1799(10-12):726-39. PubMed ID: 20601279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors selectively suppress expression of HDAC7.
    Dokmanovic M; Perez G; Xu W; Ngo L; Clarke C; Parmigiani RB; Marks PA
    Mol Cancer Ther; 2007 Sep; 6(9):2525-34. PubMed ID: 17876049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
    Bai G; Wei D; Zou S; Ren K; Dubner R
    Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between adipokines and myokines in fat browning.
    Rodríguez A; Becerril S; Ezquerro S; Méndez-Giménez L; Frühbeck G
    Acta Physiol (Oxf); 2017 Feb; 219(2):362-381. PubMed ID: 27040995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myokines: The endocrine coupling of skeletal muscle and bone.
    Gomarasca M; Banfi G; Lombardi G
    Adv Clin Chem; 2020; 94():155-218. PubMed ID: 31952571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue.
    Li F; Li Y; Duan Y; Hu CA; Tang Y; Yin Y
    Cytokine Growth Factor Rev; 2017 Feb; 33():73-82. PubMed ID: 27765498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of histone deacetylases in bone development and skeletal disorders.
    Wang JS; Yoon SH; Wein MN
    Bone; 2021 Feb; 143():115606. PubMed ID: 32829038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.